Last week, we posted about the NC House Bill 709, short titled “Protect and Put NC Back to Work”. The proposed bills aim is to reform the current North Carolina Workers’ Compensation Act. In that post, we asked for some reader feedback on what you thought about the bill. Today, the response…
Yesterday, NC House Bill 709 (Protect and Put NC Back to Work) was filed in the North Carolina House. The bill aims to reform the current North Carolina Workers’ Compensation Act to: Define “Suitable Employment” pertaining to an employers return to work within restrictions or after reaching maximum improvement. Make willful misrepresentations…
Yesterday, in the North Carolina General Assembly, a draft of a bill which proposes to protect drug makers and those selling medications from liability lawsuits was discussed. The drugs and medications protected by this proposed bill must be approved by any state or federal government agency. The bill is expected…
The Hardison & Cochran Weekly Motorcycle Newsletter has been sent out. Click here to view this week’s look into the world of motorcycles.
March is Brain Injury Awareness Month and The Brain Injury Association of America is urging everyone to “get the facts” on concussions. “A concussion is a brain injury. Period”, states the organizations website. More from the BIAA website: A concussion is caused by a bump, blow or jolt to the…
Hardison & Cochran Managing Partner, Benjamin Cochran, was recently nominated to a three year term on the North Carolina Workers’ Compensation Section Council. Mr. Cochran was elected during the Workers’ Compensation Section’s Annual Meeting held on February 11-12 in Greensboro, North Carolina. His three year term will begin on July…
Last week, we posted about the North Carolina Senate Bill 33, which is proposing to cap non-economic medical malpractice claims in North Carolina at $250,000. As a reminder, non-economic damages include pain, suffering, inconvenience, loss of consortium, physical impairment, disfigurement, and other non pecuniary damages. Most on the above list are self explanatory,…
In a late December blog post, we featured a story in the New York Times on a FDA approval process used by DePuy to get the ASR Hip Replacement system to market faster without any clinical testing. To put that blog post in a nutshell, where drugs have to be tested through a…
Yesterday, Hardison & Cochran filed the first of many cases against DePuy Orthopaedics, Inc., and its parent company, Johnson & Johnson. In August 2010, Depuy Orthopaedics recalled two of their hip replacement systems. The recall has been issued for approximately 93,000 defective implants after it was found that the device was…
UPDATE (July 27th, 2011): The North Carolina House overrode Gov. Purdue’s veto of this bill. To view a PDF version of the final bill, please click here. The North Carolina Senate Bill 33, which can be viewed here in PDF, is a proposal to reform medical malpractice in the state of North…
